Daniel J. Anderson

7.0k total citations · 1 hit paper
27 papers, 2.2k citations indexed

About

Daniel J. Anderson is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Daniel J. Anderson has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Daniel J. Anderson's work include Nuclear Structure and Function (8 papers), RNA Research and Splicing (8 papers) and Ubiquitin and proteasome pathways (6 papers). Daniel J. Anderson is often cited by papers focused on Nuclear Structure and Function (8 papers), RNA Research and Splicing (8 papers) and Ubiquitin and proteasome pathways (6 papers). Daniel J. Anderson collaborates with scholars based in United States, Australia and Germany. Daniel J. Anderson's co-authors include Martin W. Hetzer, Jesse D. Vargas, Emily M. Hatch, Maximiliano A. D’Angelo, Mary J. C. Ludlam, Peter K. Jackson, Lindsay S. Garrenton, Jian Wu, Ira Mellman and Till Maurer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Daniel J. Anderson

27 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

2012 479 citations Till Maurer, Lindsay S. Garrenton et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Anderson United States	17	1.8k	609	258	114	111	27	2.2k
Catriona Marshall United Kingdom	16	1.5k 0.8×	483 0.8×	424 1.6×	120 1.1×	156 1.4×	29	2.1k
Lee Jamieson United States	17	1.6k 0.9×	385 0.6×	490 1.9×	63 0.6×	110 1.0×	21	2.2k
Lingyan Jin China	10	1.1k 0.6×	326 0.5×	277 1.1×	138 1.2×	111 1.0×	23	1.4k
Martina Koeva United States	7	1.7k 0.9×	502 0.8×	234 0.9×	105 0.9×	75 0.7×	12	2.0k
Christopher C. Williams United States	11	1.5k 0.8×	382 0.6×	355 1.4×	112 1.0×	144 1.3×	15	1.8k
Klaus Godl Germany	20	1.0k 0.5×	154 0.3×	281 1.1×	112 1.0×	57 0.5×	23	1.5k
Ben Hodgson United Kingdom	12	2.0k 1.1×	401 0.7×	688 2.7×	60 0.5×	256 2.3×	13	2.4k
Matthew J. Schibler United States	13	1.3k 0.7×	394 0.6×	351 1.4×	100 0.9×	165 1.5×	17	1.6k
Russell Bell United States	19	1.1k 0.6×	172 0.3×	199 0.8×	96 0.8×	197 1.8×	29	1.7k
Christopher J. Morrow United Kingdom	19	976 0.5×	326 0.5×	652 2.5×	156 1.4×	223 2.0×	47	1.7k

Countries citing papers authored by Daniel J. Anderson

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Anderson more than expected).

Fields of papers citing papers by Daniel J. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Anderson. The network helps show where Daniel J. Anderson may publish in the future.

Co-authorship network of co-authors of Daniel J. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Anderson. A scholar is included among the top collaborators of Daniel J. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Anderson. Daniel J. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Hyein, Eun Ryoung Jang, Patricia G. Wilson, Daniel J. Anderson, & Emilia Galperin. (2019). VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology. Molecular Biology of the Cell. 30(14). 1655–1663. 8 indexed citations

Assimon, Victoria A., Jesse D. Vargas, Grace J. Lee, et al.. (2019). CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity. ACS Chemical Biology. 14(2). 236–244. 63 indexed citations

Anderson, Daniel J., Ronan Le Moigne, Stevan Djakovic, et al.. (2015). Abstract DDT02-01: Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer. Cancer Research. 75(15_Supplement). DDT02–1. 2 indexed citations

Zhou, Han-Jie, Jinhai Wang, Bing Yao, et al.. (2015). Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). Journal of Medicinal Chemistry. 58(24). 9480–9497. 146 indexed citations

Moigne, Ronan Le, Steve Wong, Ferdie Soriano, et al.. (2014). Abstract 951: CB-5083 is a novel first in class p97 inhibitor that disrupts cellular protein homeostasis and demonstrates anti-tumor activity in solid and hematological models. Cancer Research. 74(19_Supplement). 951–951. 1 indexed citations

Vargas, Jesse D., Emily M. Hatch, Daniel J. Anderson, & Martin W. Hetzer. (2012). Transient nuclear envelope rupturing during interphase in human cancer cells. Nucleus. 3(1). 88–100. 197 indexed citations

Wong, Chihunt, Daniel J. Anderson, Erinna F. Lee, W. Douglas Fairlie, & Mary J. C. Ludlam. (2012). Direct visualization of Bcl-2 family protein interactions using live cell fluorescent protein redistribution assays. Cell Death and Disease. 3(3). e288–e288. 10 indexed citations

Maurer, Till, Lindsay S. Garrenton, Angela Oh, et al.. (2012). Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proceedings of the National Academy of Sciences. 109(14). 5299–5304. 479 indexed citations breakdown →

Mérino, Delphine, Seong Lin Khaw, Stefan Glaser, et al.. (2012). Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. Blood. 119(24). 5807–5816. 160 indexed citations

10.

Anderson, Daniel J., Jenni Durieux, Kyung Song, et al.. (2011). Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics. PLoS ONE. 6(8). e22607–e22607. 9 indexed citations

11.

Winski, Shannon L., Daniel J. Anderson, Karyn Bouhana, et al.. (2010). 162 MEK162 (ARRY-162), a novel MEK 1/2 inhibitor, inhibits tumor growth regardless of KRas/Raf pathway mutations. European Journal of Cancer Supplements. 8(7). 56–56. 22 indexed citations

12.

Anderson, Daniel J., et al.. (2009). Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo. The Journal of Cell Biology. 186(2). 183–191. 87 indexed citations

13.

Anderson, Daniel J. & Martin W. Hetzer. (2008). Reshaping of the endoplasmic reticulum limits the rate for nuclear envelope formation. The Journal of Cell Biology. 182(5). 911–924. 165 indexed citations

14.

Anderson, Daniel J. & Martin W. Hetzer. (2008). The life cycle of the metazoan nuclear envelope. Current Opinion in Cell Biology. 20(4). 386–392. 37 indexed citations

15.

Anderson, Daniel J. & Martin W. Hetzer. (2007). Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum. Nature Cell Biology. 9(10). 1160–1166. 158 indexed citations

16.

D’Angelo, Maximiliano A., et al.. (2006). Nuclear Pores Form de Novo from Both Sides of the Nuclear Envelope. Science. 312(5772). 440–443. 173 indexed citations

17.

Anderson, Daniel J., et al.. (2005). Cik1 Targets the Minus-End Kinesin Depolymerase Kar3 to Microtubule Plus Ends. Current Biology. 15(15). 1420–1427. 107 indexed citations

18.

Lee, Hsin‐Chen, et al.. (1991). Genetic Markers in Human Bone: I. Deoxyribonucleic Acid (DNA) Analysis. Journal of Forensic Sciences. 36(2). 320–330. 35 indexed citations

19.

Anderson, Daniel J.. (1991). Choosing the right antibacterial agent. Postgraduate Medicine. 90(3). 153–165. 4 indexed citations

20.

Band, Vimla, Anita P. Hoffer, Hamid Band, et al.. (1986). Cytocidal effects of gossypol and its optical isomers on reproductive cancer cell lines. Gynecologic Oncology. 23(2). 261–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact